发明名称 |
Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
摘要 |
The invention relates to the use of substances which are specific to CEACAM8 for the manufacture of a medicament for the prophylactic or therapeutic treatment of human autoimmune diseases and/or gout. Another object of the invention concerns the use of CEACAM8-specific substances for apoptosis induction in-vitro. The invention also relates to a method for screening substances which induce apoptosis and a method for inducing apoptosis in human granulocytes.
|
申请公布号 |
EP1780220(A1) |
申请公布日期 |
2007.05.02 |
申请号 |
EP20050090302 |
申请日期 |
2005.11.01 |
申请人 |
|
发明人 |
|
分类号 |
C07K16/28;A61K39/395;A61P17/06;A61P19/02;A61P19/06;A61P37/02 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|